Analysis of Nuclear Receptor Coactivator 5 (NCOA5) Messenger RNA Expression and rs2903908 Single Nucleotide Polymorphism of NCOA5 in an Egyptian Cohort with Behçet’s Disease: A Single-Center Case-control Study

ABSTRACT

The nuclear receptor coactivator 5 (NCOA5) has been linked to several inflammatory disorders, including Behçet’s disease (BD). We evaluated the expression of NCOA5 messenger RNA (mRNA) using real-time reverse transcription-polymerase chain reaction, and analyzed the rs2903908 T > C of NCOA5 using TaqMan allelic discrimination assay in 49 Egyptian BD patients and 50 controls. The NCOA5 mRNA levels were higher in patients compared to controls (p = .02), female patients compared to males (p = .037), and in patients with ocular involvement (p = .049). Non-CC genotype carriers had a higher frequency of articular manifestations compared with CC carriers (p = .047). Genotypes CC + CT were associated with reduced risk of cutaneous involvement (OR = 0.27, p = .04). CC carriers with active BD or cutaneous manifestations displayed significantly lower NCOA5 mRNA expression than TT carriers. Our results demonstrate that NCOA5 is linked to BD clinical findings and activity.

KEYWORDS:

• NCOA5
• Ocular Behçet’s disease
• mRNA
• real-time polymerase chain reaction
• rs2903908

Acknowledgments

The authors express sincere appreciation to Dr. Eman Ali Toriah, Research Assistant Professor, Department of Surgery, Tulane University, for her expert advice and support during the execution of this work.

Disclosure statement

The authors report no conflict of interest.

Supplemental Material

Supplemental data for this article can be accessed on the publisher’s website.

Additional information

Funding

This work was partially supported by Cairo University.